Regent Pacific FY26 H1 returns to profit of US$544,000; revenue rises to US$5.28 million

• Regent Pacific swung to a profit of US$544,000 from a loss of US$2.22 million a year earlier.
• Revenue more than doubled to US$5.28 million, while operating profit turned to US$2.38 million from an operating loss of US$2.01 million.
• Trade receivables jumped 6,263% to US$5.22 million, mainly due to a US$5 million Senstend milestone receivable from Fosun Wanbang.
• NMPA approved Senstend in China on June 10, triggering the US$5 million milestone; another US$2 million is payable on first China sale.
• Deep Longevity posted US$69,000 in revenue and targets a US consumer digital telehealth launch in the final quarter of 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regent Pacific Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260921-12339287), on September 21, 2026, and is solely responsible for the information contained therein.